astir 700 surfactant
nutrien ag solutions limited - soyal phospholipids; propionic acid - dispersible concentrate - soyal phospholipids ungrouped active 350.0 g/l; propionic acid acid-general active 350.0 g/l - adjuvant
ibugesic
rex medical ltd - ibuprofen 200mg; ibuprofen 200mg - film coated tablet - 200 mg - active: ibuprofen 200mg excipient: colloidal silicon dioxide hypromellose e-15 magnesium stearate maize starch propylene glycol purified talc purified water sodium laurilsulfate titanium dioxide active: ibuprofen 200mg excipient: colloidal silicon dioxide hypromellose e-15 magnesium stearate maize starch methyl hydroxybenzoate propyl hydroxybenzoate propylene glycol purified talc purified water sodium laurilsulfate titanium dioxide - ibugesic tablets are indicated for analgesic and anti-inflammatory effect in the treatment of rheumatoid arthritis (including juvenile rheumatoid arthritis or still's disease), ankylosing spondylitis, osteoarthritis and other non-rheumatoid (seronegative) arthropathies. in the treatment of non-articular rheumatic conditions, ibugesic tablets are indicated in periarticular conditions such as frozen shoulder (capsulitis), bursitis, tendonitis, tenosynovitis and low-back pain. ibugesic tablets can also be used in soft-tissue injuries such as sprains and strains. ibugesic tablets are also indicated for its analgesic effect in the relief of mild to moderate pain such as dysmenorrhoea, dental and post-operative pain. ibugesic tablets are also indicated for the relief of neuralgia, migraine, headache, feverishness and for the relief of the symptoms of cold and influenza.
simbrinza
novartis new zealand ltd - brimonidine tartrate 2 mg/ml; ; brinzolamide 10 mg/ml; - eye drops, suspension - 1%/0.2% - active: brimonidine tartrate 2 mg/ml brinzolamide 10 mg/ml excipient: benzalkonium chloride boric acid carbomer 974 hydrochloric acid mannitol propylene glycol purified water sodium chloride sodium hydroxide tyloxapol - decrease of elevated intraocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction.
mylan-naproxen ec tablet (enteric-coated)
mylan pharmaceuticals ulc - naproxen - tablet (enteric-coated) - 500mg - naproxen 500mg - other nonsteroidal antiimflammatory agents
teva-naproxen ec tablet (enteric-coated)
teva canada limited - naproxen - tablet (enteric-coated) - 250mg - naproxen 250mg - other nonsteroidal antiimflammatory agents
teva-naproxen ec tablet (enteric-coated)
teva canada limited - naproxen - tablet (enteric-coated) - 375mg - naproxen 375mg - other nonsteroidal antiimflammatory agents
teva-naproxen ec tablet (enteric-coated)
teva canada limited - naproxen - tablet (enteric-coated) - 500mg - naproxen 500mg - other nonsteroidal antiimflammatory agents
mylan-naproxen ec tablet (enteric-coated)
mylan pharmaceuticals ulc - naproxen - tablet (enteric-coated) - 250mg - naproxen 250mg - other nonsteroidal antiimflammatory agents
mylan-naproxen ec tablet (enteric-coated)
mylan pharmaceuticals ulc - naproxen - tablet (enteric-coated) - 375mg - naproxen 375mg - other nonsteroidal antiimflammatory agents
apo-naproxen ec tablets tablet (enteric-coated)
apotex inc - naproxen - tablet (enteric-coated) - 250mg - naproxen 250mg - other nonsteroidal antiimflammatory agents